DOXORUBICIN, CYCLOPHOSPHAMIDE, AND 5-FLUOROURACIL IN PATIENTS WITH CARCINOMA OF THE CERVIX OR VAGINA

  • 1 January 1980
    • journal article
    • research article
    • Vol. 64  (4-5) , 549-551
Abstract
Evaluable patients (36) with carcinoma of the uterine cervix or vagina not amenable to surgery or radiation therapy were treated with doxorubicin, cyclophosphamide and 5-fluorouracil; 16.5% of the patients responded, with 2.7% having a complete response. Only 4 (11.17%) of the 36 patients are alive, all with persistent malignancy; none of the responders are alive. Because of the low response and survival rates, this combination is not recommended for women with recurrent cervical or vaginal carcinoma.

This publication has 1 reference indexed in Scilit: